These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25248880)

  • 21. Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.
    O'Leary L; van der Sloot AM; Reis CR; Deegan S; Ryan AE; Dhami SP; Murillo LS; Cool RH; Correa de Sampaio P; Thompson K; Murphy G; Quax WJ; Serrano L; Samali A; Szegezdi E
    Oncogene; 2016 Mar; 35(10):1261-70. PubMed ID: 26050621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.
    Yang J; LeBlanc FR; Dighe SA; Hamele CE; Olson TL; Feith DJ; Loughran TP
    Blood; 2018 Jun; 131(25):2803-2815. PubMed ID: 29699990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
    Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
    J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
    Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
    Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
    Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
    Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells.
    Sanlioglu AD; Dirice E; Aydin C; Erin N; Koksoy S; Sanlioglu S
    BMC Cancer; 2005 May; 5():54. PubMed ID: 15916713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protein expression and clinical significance of cyclooxygenase 2 and nuclear factor kappa B in gastric mucosa-associated lymphoid tissue lymphoma].
    Wu XL; Han SL; Wan L; Huang KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):163-6. PubMed ID: 18344086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells.
    Sanlioglu AD; Karacay B; Koksal IT; Griffith TS; Sanlioglu S
    Cancer Gene Ther; 2007 Dec; 14(12):976-84. PubMed ID: 17853923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
    Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
    Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
    Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
    Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2).
    Ghosal N; Tapadar P; Biswas D; Pal R
    Mol Biol Rep; 2024 May; 51(1):671. PubMed ID: 38787503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells.
    Aydin C; Sanlioglu AD; Karacay B; Ozbilim G; Dertsiz L; Ozbudak O; Akdis CA; Sanlioglu S
    Hum Gene Ther; 2007 Jan; 18(1):39-50. PubMed ID: 17187448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of apoptosis in periodontitis.
    Lucas H; Bartold PM; Dharmapatni AA; Holding CA; Haynes DR
    J Dent Res; 2010 Jan; 89(1):29-33. PubMed ID: 19948942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.